Skip to main content

Nifty holds but internals keep slipping — treat it with suspicion

Fast breadth eroding, net Stage-2 flow negative, and Thursday's 1.1% index gain masked a 703-to-1,498 rout.

Monday, 20 July 20262 min readStage2Stocks Market Desk

Nifty 50
24,239
-0.4% on the day
Market
Neutral — Building
34 sessions in this state
Breadth
43%
above 200-DMA · narrow
Adv / Dec
1,145 / 1,072
advancers ahead
52w highs / lows
166 / 95
net +71
Stage-2 share
34%
cohort widening

The tape is hollowing out, not dipping inside strength. Nifty sits at 24,238.5, down 0.4% and below its 200-day average, but the real story is that participation has been deteriorating for five straight sessions while the index treads water — that is distribution, not consolidation. Until the fast breadth gauge stops sliding and the Stage-2 flow turns net positive, surface-level index stability is noise.

What the internals are saying

The slow structural gauge — the share of stocks above their 200-day average — has barely moved, sitting at 43%, which looks stable. The fast short-term gauge tells a different story: it peaked at 52% on 13 July and has ground down to 42% today, with Thursday's 1.1% index pop accompanied by only 703 advancers against 1,498 decliners and net new highs collapsing to 39 — the worst reading in this six-session window. Today's advance-decline of 1,145 to 1,072 is marginally positive but does nothing to repair that damage. Over the last five days, 60 stocks rotated out of Stage 2 into Stage 3 against only 46 moving in the other direction — a net drain of 14 — and the Stage-2 cohort itself has slipped from 35.2% to 34.3% over the same stretch. The trajectory is breadth eroding, and a single day of mild advancer leadership does not change that verdict.

Where leadership sits

Defensives led on the day — Utilities up 1.6%, Health Care up 1.2%, Materials up 0.8% — which is not the sector rotation you want to see if you are arguing for a resumption of the prior advance. Health Care is the one sector where the structural case holds: it leads over one month and three months, and its Stage-2 cohort is expanding fastest among all sectors, with Wanbury and RPG Life Sciences both clearing the screen. Consumer Discretionary and Information Technology are also seeing their Stage-2 cohorts widen, though IT remains a three-month laggard at -4.5% and that expansion is coming off a low base. The screen surfaces names — the setups table below shows what cleared today — but in a tape where participation is shrinking and net Stage-2 flow is negative, fewer of those setups will follow through than the scores alone suggest.

Leading Stage-2 setups
StockSectorSetup% 1D
Tirupati Forge LtdConsumer Discretionary10.0+2.6%
Lokesh Machines LtdIndustrials9.8+2.0%
Wanbury LtdHealth Care9.3+2.3%
Signpost India LtdCommunication Services9.3-2.1%
Triveni Engineering and Industries LtdConsumer Staples9.3-0.4%
RPG Life Sciences LtdHealth Care9.2+5.5%
Bharat Seats LtdConsumer Discretionary9.0-1.8%
Gandhar Oil Refinery (INDIA) LtdEnergy9.0+9.8%
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Utilities+1.6%-1.0%+6.3%6318%
Health Care+1.2%+6.7%+17.6%7451%
Materials+0.8%-0.6%+2.5%6934%
Communication Services+0.7%+3.7%+10.7%6518%
Consumer Staples+0.6%-0.4%+0.8%5527%
Industrials+0.4%-1.2%+10.7%6838%
Energy+0.2%+0.9%-1.0%5629%
Consumer Discretionary+0.0%+2.3%+4.0%6736%
Real Estate-0.1%+10.1%+15.5%5225%
Information Technology-0.3%+1.5%-4.5%4028%
Financials-0.3%+0.9%-0.4%6135%
Share of NSE stocks in Stage 2Jan 2026 – Jul 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26Nifty 50Stocks in Stage 2Latest: 35%
The share of NSE stocks in Stage 2 over the six months to this wrap, with the Nifty's shape above it: the market underneath the day's numbers. Source: Stage2Stocks classification of every NSE stock with enough history, each week.
Try it on Stage2StocksHow to read this chart Lesson 3 of the course: why the Nifty isn't the market, and what the share of stocks in Stage 2 tells you.

Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →